Evogene Ltd Ord (EVGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 11,317 | 9,484 | 11,915 | 20,772 | 27,331 |
| Marketable Securities | 8,636 | 11,424 | 14,698 | 10,291 | 9,896 |
| Receivables | 3,950 | 4,072 | 3,693 | 3,330 | 3,215 |
| Inventories | 1,456 | 794 | 716 | 76 | 113 |
| TOTAL | $25,359 | $25,774 | $31,022 | $34,469 | $40,555 |
| Non-Current Assets | |||||
| PPE Net | 1,562 | 1,650 | 1,796 | 2,455 | 2,535 |
| Investments And Advances | 134 | 130 | 133 | 28 | 0 |
| Intangibles | 12,440 | 12,685 | 12,924 | 13,169 | 13,414 |
| Other Non-Current Assets | 619 | 729 | 905 | 980 | 1,242 |
| TOTAL | $14,755 | $15,194 | $15,758 | $16,632 | $17,191 |
| Total Assets | $40,114 | $40,968 | $46,780 | $51,101 | $57,746 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,356 | 1,773 | 2,005 | 2,804 | 2,198 |
| Accrued Expenses | 2,289 | 2,333 | 2,432 | 2,537 | 2,059 |
| Other current liabilities | 17,484 | 681 | 561 | 388 | 634 |
| TOTAL | $23,288 | $5,893 | $6,129 | $6,944 | $6,484 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 742 | 548 | 416 | 362 | 739 |
| Other Non-Current Liabilities | 5,006 | 15,457 | 14,848 | 15,815 | 15,273 |
| TOTAL | $4,588 | $15,135 | $15,268 | $15,472 | $15,399 |
| Total Liabilities | $27,876 | $21,028 | $21,397 | $22,416 | $21,883 |
| Shareholders' Equity | |||||
| Common Shares | 301 | 287 | 286 | 286 | 286 |
| Retained earnings | -274,498 | -266,868 | -261,449 | -257,586 | -250,985 |
| Other shareholders' equity | 16,581 | 16,873 | 17,094 | 16,632 | 17,353 |
| TOTAL | $12,238 | $19,940 | $25,383 | $28,685 | $35,863 |
| Total Liabilities And Equity | $40,114 | $40,968 | $46,780 | $51,101 | $57,746 |